Dr. Doris Urlaub

Wissenschaftliche Mitarbeiterin

Hier finden Sie die Schlüsselpublikationen ab 2010, die am IfADo entstanden sind. Für alle anderen Veröffentlichungen unserer wissenschaftlichen Mitarbeiter beachten Sie bitte die Links zu anderen Datenbanken wie Pubmed.

Urlaub D, Wolfsdorff N, Hoffmann J-E, Dorok S, Hoffmann M, Anft M, Pieris N, Günther P, Schaaf B, Cassens U, Bröde P, Claus M, Picard LK, Wingert S, Backes S, Durak D, Babel N, Pöhlmann S, Renken F, Raunser S, Watzl C:

Neutralizing antibody responses 300 days after SARS-CoV-2 infection and induction of high antibody titers after vaccination. Eur J Immunol 52: 810-815 (2022)

Urlaub D, Wolfsdorff N, Durak D, Renken F, Watzl C:

SARS-CoV-2 infection shortly after BNT162b2 vaccination results in high anti-spike antibody levels in nursing home residents and staff. Immun Inflamm Dis 9: 1702–1706 (2021)

Urlaub D, Watzl C:

Coated latex beads as artificial cells for quantitative investigations of receptor/ligand interactions. Curr Protoc Immunol 131: e111 (2020) (12 pp)

Anft M, Netter P, Urlaub D, Prager I, Schaffner S, Watzl C:

NK cell detachment from target cells is regulated by successful cytotoxicity and influences cytokine production. Cell Mol Immunol 17: 347–355 (2020)

Dorsch M, Urlaub D, Bönnemann V, Bröde P, Sandusky M, Watzl C:

Quantitative analysis of human NK cell reactivity using latex beads coated with defined amounts of antibodies. Eur J Immunol 50: 656-665 (2020)

Urlaub D, Zhao S, Blank N, Bergner R, Claus M, Tretter T, Lorenz HM, Watzl C, Merkt W:

Activation of natural killer cells by rituximab in granulomatosis with polyangiitis. Arthritis Res Ther 21(1): 277 (2019) (11 pp)

Urlaub D, Höfer K, Müller M-L, Watzl C:

LFA-1 activation in NK cells and their subsets: influence of receptors, maturation, and cytokine stimulation. J Immunol 198: 1944-1951 (2017)

Urlaub D, Bhat R, Messmer B, Watzl C:

Co-activation of cultured human natural killer cells: enhanced function and decreased inhibition. J Toxicol Environ Health 79A: 1078-1084 (2016)

Watzl C, Urlaub D:

Molecular mechanisms of natural killer cell regulation. Front Biosci (Landmark ed.) 17: 1418-1432 (2012)

Mesecke S, Urlaub D, Busch H, Eils R, Watzl C:

Integration of activating and inhibitory receptor signaling by regulated phosphorylation of Vav1 in immune cells. Sci Signal 4(175): ra36 (2011) (9 pp)

Hier finden Sie die Publikationen ab 2010, die am IfADo entstanden sind. Für alle anderen Veröffentlichungen unserer wissenschaftlichen Mitarbeiter beachten Sie bitte die Links zu anderen Datenbanken wie Pubmed.

Claus M, Pieris N, Urlaub D, Bröde P, Schaaf B, Durak D, Renken F, Watzl C:

Early expansion of activated adaptive but also exhausted NK cells during acute severe SARS-CoV-2 infection. Front Cell Infect Microbiol 13: 1266790 (2023) (8 pp)

Simsek A, Bessen C, Meister TL, Urlaub D, Skaletz-Rorowski A, Brockmeyer NH, Overheu O, Reinacher-Schick A, Faissner S, Watzl C, Pfaender S, Schmitz I, Potthoff A, Plaza-Sirvent C:

Humoral and cellular immune responses to repeated SARS-CoV-2 infection and vaccination in an individual living with HIV. (Letter to the editor). J Eur Acad Dermatol Venereol 37: e825-e827 (2023)

Bröde P, Claus M, Urlaub D, Wolfsdorff N, Watzl C:

Das Immunalter von Feuerwehrmännern ist feminin. In: Gesellschaft für Arbeitswissenschaft (Hrsg.): Nachhaltig Arbeiten und Lernen – Analyse und Gestaltung lernförderlicher und nachhaltiger Arbeitssysteme und Arbeits- und Lernprozesse. 69. Kongress der Gesellschaft für Arbeitswissenschaft, Hannover, 01.-03.03. 2023 (Beitrag B.3.3 (4 S)). Sankt Augustin: GfA-Press, 2023

Faissner S, Heitmann N, Plaza-Sirvent C, Trendelenburg P, Ceylan U, Motte J, Bessen C, Urlaub D, Watzl C, Overheu O, Reinacher-Schick A, Hellwig K, Pfaender S, Schmitz I, Gold R:

Immune response in ofatumumab treated multiple sclerosis patients after SARS-CoV-2 vaccination. Front Immunol 13: 980526 (2022) (13 pp)

Bessen C, Plaza-Sirvent C, Simsek Agit, BJ, Marheinecke C, Urlaub D, Bonowitz P, Busse S, Schumann S, Blanco EV, Skaletz-Rorowski A, Brockmeyer NH, Overheu O, Reinacher-Schick A, Faissner S, Watzl C, Pfaender S, Potthoff A, Schmitz I:

Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIV. Front Immunol 13: 1049070 (2022) (13 pp)

Heinen N, Marheinecke CS, Bessen C, Blazquez-Navarro A, Roch T, Stervbo U, Anft M, Plaza-Sirvent C, Busse S, Klöhn M, Schrader J, Vidal Blanco E, Urlaub D, Watzl C, Hoffmann M, Pöhlmann S, Tenbusch M, Steinmann E, Todt D, Hagenbeck C, Zimmer G, Schmidt WE, Quast DR, Babel N, Schmitz I, Pfänder S:

In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant. Front Immunol 13: 1062210 (2022) (14 pp)

Neutralizing antibody responses 300 days after SARS-CoV-2 infection and induction of high antibody titers after vaccination. Eur J Immunol 52: 810-815 (2022)

Urlaub D, Wolfsdorff N, Durak D, Renken F, Watzl C:

SARS-CoV-2 infection shortly after BNT162b2 vaccination results in high anti-spike antibody levels in nursing home residents and staff. Immun Inflamm Dis 9: 1702–1706 (2021)

Anft M, Netter P, Urlaub D, Prager I, Schaffner S, Watzl C:

NK cell detachment from target cells is regulated by successful cytotoxicity and influences cytokine production. Cell Mol Immunol 17: 347–355 (2020)

Dorsch M, Urlaub D, Bönnemann V, Bröde P, Sandusky M, Watzl C:

Quantitative analysis of human NK cell reactivity using latex beads coated with defined amounts of antibodies. Eur J Immunol 50: 656-665 (2020)

Urlaub D, Watzl C:

Coated latex beads as artificial cells for quantitative investigations of receptor/ligand interactions. Curr Protoc Immunol 131: e111 (2020) (12 pp)

Claus M, Urlaub D, Fasbender F, Watzl C:

SLAM family receptors in natural killer cells – Mediators of adhesion, activation and inhibition via cis and trans interactions. Clin Immunol 204: 37-42 (2019)

Prager I, Liesche C, van Ooijen H, Urlaub D, Verron Q, Sandström N, Fasbender F, Claus M, Eils R, Beaudouin J, Önfelt B, Watzl C:

NK cells switch from granzyme B to death receptor-mediated cytotoxicity during serial killing. J Exp Med 216: 2113-2127 (2019)

Urlaub D, Zhao S, Blank N, Bergner R, Claus M, Tretter T, Lorenz HM, Watzl C, Merkt W:

Activation of natural killer cells by rituximab in granulomatosis with polyangiitis. Arthritis Res Ther 21(1): 277 (2019) (11 pp)

Liesche C, Sauer P, Prager I, Urlaub D, Claus M, Eils R, Beaudouin J, Watzl C:

Single-fluorescent protein reporters allow parallel quantification of natural killer cell-mediated granzyme and caspase activities in single target cells. Front Immunol 9: 1840 (2018) (12 pp)